Tag: covid
-
![Predictmedix (PMED.C) killing it on new COVID-19 screening tech]()
Predictmedix (PMED.C) killing it on new COVID-19 screening tech
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days, on the back of news it’s being used by a large events company, and financials that show a very short road to profitability. For those that haven’t been paying attention…
-
2 million new investors are buying stocks on their cellphones
Stuck at home, but armed with online trading apps, individual investors helped drive the historic comeback for stocks
-
Everything is up: Eat, drink, be merry… for tomorrow we die
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in order to save us from economic collapse, the government printed trillions of dollars and just fired it all into the markets out of a bazooka, only to establish a decades-long…
-
Revive Therapeutics’ (RVV.C) product pipeline is flowing freakishly fast
Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19)
-
Predictmedix (PMED.C) bursts out of the starting blocks with 3 big alliances
Two weeks ago, Predictmedix filed a Patent Application in the U.S. for its AI-driven rapid screening system for infectious diseases.
-
Chartwell Retirement Residences (CSH.UN.T), Extendicare (EXE.T), Sienna Senior Living (SIA.T): are Canadian parents safe in senior care homes?
Growing old is a messy business. Institutional care for seniors will never provide perfect solutions. The challenge is not to make a perfect system, but to mitigate the health risks of long term care, intelligently and ethically.
-
Revive Therapeutics (RVV.C): Kicked around, called a fraud, gets FDA approval of Phase 3 COVID-19 trials
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he put out news claiming his little pharma company, which had built a reputation for chasing aggressively into new pharmaceutical fields, had found some IP that might be useful in the…
-
Isracann (IPOT.C) closes 3-year cannabis offtake deal in Israel
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next three years. This accelerates our timeline to production and revenue.”
-
Oil prices take a dive, and Equity Guru tells you what it all means
As if 2020 has not been weird and unusual already, today the world experienced another unprecedented wacky event: negative oil prices. If anyone reading this is about to rush to the nearest gas station to get paid to fill up their tank, think again. I already tried that and it didn’t work. A more in-depth…
-
![The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials]()
The Good, the Bad & the Ugly; Trulieve Cannabis (TRUL.C), KushCo Holdings (KSHB.OTC) and Hexo (HEXO.NYSE) release financials
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than you’re borrowing but, in a down market, you’re under extra pressure to keep things together when debts come due.”
